Proteome Sciences (LON:PRM) Shares Down 5.1% – Should You Sell?

Proteome Sciences plc (LON:PRM) shares dropped 5.1% on Friday . The stock traded as low as GBX 1.50 and last traded at GBX 1.67. Approximately 538,226 shares were traded during trading, an increase of 117% from the average daily volume of 248,370 shares. The stock had previously closed at GBX 1.76.

Proteome Sciences Price Performance

The stock has a market capitalization of £5.20 million, a P/E ratio of -1.56 and a beta of 0.07. The business’s 50 day simple moving average is GBX 2.43 and its two-hundred day simple moving average is GBX 2.85. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66.

Proteome Sciences (LON:PRM) last posted its earnings results on Thursday, September 25th. The company reported GBX (0.73) EPS for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.